Medicare Enrolled

Dr. Tapan Rami, M.D.

Cardiovascular Disease · Houston, TX
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Low-engagement
6560 FANNIN ST STE 620, Houston, TX 77030
7137911978
In practice since 2006 (19 years)
NPI: 1063476885 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rami from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rami? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rami

Dr. Tapan Rami is a cardiovascular disease in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Rami performed 8,145 Medicare services across 3,416 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rami received a total of $15,648 from 43 pharmaceutical and/or device companies across 795 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rami is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 6% volume in TX$ $15,648 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,145
Medicare services
Top 6% in TX for cardiovascular disease
3,416
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~429 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec1,368$28$145
Evaluation of cardiac rhythm monitor system, remote up to 30 days983$20$125
Office visit, established patient (30-39 min)903$97$400
Remote pacemaker/defibrillator monitoring, 90 days830$17$125
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days626$20$145
Remote pacemaker monitoring, 90 days495$22$125
Electrocardiogram (EKG), 12-lead426$11$90
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days335$28$205
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic301$10$30
Programming of cardiac rhythm monitor system293$47$130
Programming of dual lead pacemaker system220$62$225
Programming of heart rhythm stimulation after drug infusion106$68$2,500
New patient office visit (45-59 min)103$134$525
Hospital follow-up visit, moderate complexity103$64$145
Programming of multiple lead implantable defibrillator system91$87$290
Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation88$787$3,550
Initial hospital admission, high complexity81$143$400
Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm77$256$1,330
Programming of dual lead implantable defibrillator system75$75$290
Office visit, established patient, complex (40-54 min)59$144$565
Insertion of catheters and destruction of tissue to treat abnormal heart rhythm53$256$1,330
Hospital follow-up visit, high complexity49$96$190
Ultrasound evaluation of heart blood vessel with review by radiologist48$60$440
Office visit, established patient (20-29 min)48$58$285
Regadenoson injection (Lexiscan) for heart stress test44$41$100
Programming of multiple lead pacemaker system42$63$200
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes32$10$50
External shock to heart to regulate heart beat31$87$571
Repair of left upper heart chamber with implant with review by radiologist27$636$2,511
Programming of single lead implantable defibrillator system26$67$225
Insertion of pacemaker and upper and lower heart chamber electrode23$432$2,750
Echocardiogram, transthoracic22$151$1,300
Initial hospital admission, moderate complexity20$108$270
Hospital follow-up visit, low complexity17$41$90
Removal of heart rhythm monitor from under the skin16$41$275
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician13$51$349
Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate)13$694$2,660
Hospital discharge day management, 30 minutes or less13$67$145
Nuclear medicine studies of heart muscle at rest and with stress and spect12$363$2,925
Insertion of heart rhythm monitor under skin11$65$280
Telephone medical discussion with physician, 5-10 minutes11$43$285
Technetium tc-99m sestamibi, diagnostic, per study dose11$64$82
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
29.7% high complexity
1.4% medium
68.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$15,648
Total received (2018-2024)
Avg $2,235/year across 7 years
Top 23% in TX for cardiovascular disease
43
Companies
795
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,602 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$46 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,067
2023
$2,158
2022
$2,954
2021
$1,998
2020
$1,304
2019
$2,158
2018
$3,009

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$3,760
Abbott Laboratories
$3,138
Medtronic Vascular, Inc.
$1,799
Biosense Webster, Inc.
$1,789
Janssen Pharmaceuticals, Inc
$1,004
Impulse Dynamics (USA) Inc.
$554
Boston Scientific Corporation
$545
E.R. Squibb & Sons, L.L.C.
$313
BIOTRONIK INC.
$279
PFIZER INC.
$275
Medical Device Business Services, Inc.
$251
CARDIVA MEDICAL, INC.
$231
Amgen Inc.
$197
SANOFI-AVENTIS U.S. LLC
$178
BOSTON SCIENTIFIC CORPORATION
$140
Bayer HealthCare Pharmaceuticals Inc.
$125
Otsuka America Pharmaceutical, Inc.
$113
Edwards Lifesciences Corporation
$111
ATRICURE, INC.
$94
Novartis Pharmaceuticals Corporation
$78
Aziyo Biologics, Inc.
$76
Inspire Medical Systems, Inc.
$64
AtriCure, Inc.
$57
AltaThera Pharmaceuticals LLC
$57
Astellas Pharma US Inc
$40
G Medical Diagnostic Services, Inc.
$39
Esperion Therapeutics, Inc.
$36
CardioFocus, Inc.
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
CVRx, Inc.
$24
Regeneron Healthcare Solutions, Inc.
$22
Novo Nordisk Inc
$22
Amarin Pharma Inc.
$21
Kestra Medical Technology Services, Inc.
$21
Merck Sharp & Dohme LLC
$20
Arrow International, Inc.
$18
Biom'Up SA
$17
Avinger Inc.
$17
Lundbeck LLC
$15
Tactile Systems Technology Inc
$14
Preventice Services, LLC
$14
iRhythm Technologies, Inc.
$13
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$11
Top 3 companies account for 55.6% of total payments
Associated products mentioned in payments ›
ACCENT · ADAPTA · ASSURITY · ATRICURE ATRICLIP LAA EXCLUSION · ATTAIN COMMAND + SUREVALVE · AURORA EV-ICD MRI SURESCAN · AVEIR · AZURE XT DR MRI SURESCAN · Accent Pacemaker · Acticor · Adapta · Advisa · Allure Quadra RF CRT Pacemaker · Arctic Front · Assure WCD · Assurity Pacemaker · Attain · Axium INS DRG IPG · Azure · Barostim Neo System · CAMZYOS · CAPSUREFIX NOVUS MRI SURESCAN · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · CLARIA MRI QUAD CRT-D SURESCAN · COBALT DR MRI SURESCAN · CONFIRM RX · CRESEMBA · CRT-Ds · Cardiac Monitoring Suite · CareLink · CareLink Express · Carto 3 · Carto 3 System · Circulatory Support · Claria MRI · Cobalt · Compia MRI · Confirm Rx · Connectivity and Remote care · Corlanor · ECM · ECM Patch · ELIQUIS · EMBLEM S ICD ELECTRODE DELIVERY SYSTEM · ENSITE · ENSITE PRECISION · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYS · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Ellipse ICD · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · Evera · FORTIFY ASSURA · Flexitouch Plus · Fortify Assura · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · Hemoblast · INSPIRE · JYNARQUE · Kerendia · LABSYSTEM · LEXISCAN · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · MICRA · MOMENTUM · MRI Ready Leads · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · Micra · NA · NEXLETOL · NORTHERA · OPTIMIZER · OPTISURE · Optimizer · Optimizer Smart System · PANTHERIS · PERCEPTA QUAD CRT-P MRI SURESCAN · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PULSESELECT · Pacemakers · Percepta · Pouch · Quadra Assura CRT Defibrillator · Quartet CRT Lead · RESONATE · Repatha · Reveal LINQ · SAPIEN 3 Ultra RESILIA · SELECTSECURE · SELECTSITE · SelectSecure · Sheath - Percutaneous · Sotalol Hydrochloride · TENDRIL · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TYRX · TactiCath Quartz CFA Catheter · UNIFY ASSURA · VERQUVO · VIGILANT · VISA AF MRI VR SURESCAN · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · ZIO Patch · Zephyr Pacemaker · i-STAT 1
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $192 per 100 Medicare services performed
Looking for a cardiovascular disease in Houston?
Compare cardiovascular diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
385
Per 100K population
8.1
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rami is a remote & electrophysiology specialist, with above-average Medicare volume (top 6% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rami experienced with interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec?
Based on Medicare claims data, Dr. Rami performed 1,368 interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rami receive payments from pharmaceutical companies?
Yes. Dr. Rami received a total of $15,648 from 43 companies across 795 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rami's costs compare to other cardiovascular diseases in Houston?
Dr. Rami's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rami) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →